IsoRay

$0.365
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0021 (-0.58%) Today
+$0.0021 (+0.58%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell IsoRay and other stocks, options, and ETFs commission-free!

About ISR

IsoRay, Inc., also called IsoRay, is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. The listed name for ISR is IsoRay, Inc.

CEO
Lori A. Woods
Employees
53
Headquarters
Richland, Washington
Founded
1983
Market Cap
31.65M
Price-Earnings Ratio
Dividend Yield
Average Volume
775.22K
High Today
$0.367
Low Today
$0.355
Open Price
$0.365
Volume
1.09M
52 Week High
$1.06
52 Week Low
$0.352

Collections

ISR Earnings

-$0.02
-$0.01
-$0.01
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Feb 9, After Hours

You May Also Like